PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
34852652-0	2021	Assessing the Structural and Functional Similarity of Insulin Glargine Biosimilars.	Insulin Glargine	62-70	insulin	Homo sapiens	54-61	
34852652-2	2021	Only a few reports of thorough evaluation of the quality of insulin glargine biosimilars are available in literature.	Insulin Glargine	68-76	insulin	Homo sapiens	60-67	
34852652-3	2021	Here, we examine the structural and functional similarity of biosimilars of insulin glargine, the first basal long-acting insulin analogue with respect to its innovator product (Lantus  from Sanofi Aventis).	Insulin Glargine	84-92	insulin	Homo sapiens	76-83	
34852652-3	2021	Here, we examine the structural and functional similarity of biosimilars of insulin glargine, the first basal long-acting insulin analogue with respect to its innovator product (Lantus  from Sanofi Aventis).	Insulin Glargine	84-92	insulin	Homo sapiens	122-129	
34852652-10	2021	CONCLUSIONS: While an overall structural and functional similarity was observed across insulin glargine biosimilars with respect to the innovator product, low amounts of product-related variants were seen in some biosimilars and these impact product stability.	Insulin Glargine	95-103	insulin	Homo sapiens	87-94